CDK2-IN-59 is a CDK2 inhibitor with a IC50 of 66.33 µM. CDK2-IN-59 stably interacts within the CDK2 active site and induces apoptosis in breast cancer cells. CDK2-IN-59 can be used for the research of breast cancer[1].
Molecular Weight:
475.88
Formula:
C24H18ClN5O4
Target:
Apoptosis,CDK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
